progenity
present
precision
medicine
abstracts
american
college
gastroenterology
acg
virtual
annual
meeting
october
san
diego
globe
newswire
progenity
nasdaq
prog
biotechnology
company
established
track
record
success
developing
commercializing
molecular
testing
products
pleased
announce
two
abstracts
related
progenity
ingestible
technologies
diagnosis
treatment
gastrointestinal
disorders
accepted
presentation
american
college
gastroenterology
acg
virtual
annual
meeting
set
take
place
october
progenity
presenting
one
oral
presentation
one
poster
presentation
accepted
abstract
titles
study
findings
part
event
sessions
virtual
hall
embargoed
october
est
coincide
start
acg
virtual
annual
scientific
meeting
information
abstracts
made
available
progenity
website
following
conference
progenity
progenity
biotechnology
company
established
track
record
success
developing
commercializing
molecular
testing
products
well
innovating
field
precision
medicine
progenity
provides
vitro
molecular
tests
designed
improve
lives
providing
actionable
information
helps
guide
patients
physicians
making
medical
decisions
key
life
stages
company
applies
approach
combining
genomics
epigenomics
proteomics
metabolomics
molecular
testing
products
development
suite
investigational
ingestible
devices
designed
provide
precise
diagnostic
sampling
drug
delivery
solutions
progenity
vision
transform
healthcare
become
precise
personal
improving
diagnoses
disease
improving
patient
outcomes
localized
treatment
targeted
therapies
additional
information
progenity
please
visit
company
website
investor
contact
robert
uhl
managing
director
westwicke
icr
ir
media
contact
kate
cg
life
kblomlowery
